盤龍藥業(002864.SZ):與西北大學生命科學與健康研究院達成戰略合作協議
格隆匯12月10日丨盤龍藥業(002864.SZ)公佈,公司近日與西北大學生命科學與健康研究院為充分發揮雙方在各自領域的資源優勢,進一步推動雙方長期、全面、深入的合作,共同發掘、培育市場,本着長期合作、平等互利、協商一致的原則,經過友好協商,達成戰略合作協議。
公司與西北大學生命科學與健康研究院合作有利於充分發揮各自資源優勢,進行研發工作,有利於公司新產品業務研發的發展。此次簽署的戰略合作協議對公司本年度財務狀況及經營業績不構成重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.